The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma
Abstract
Purpose: Hodgkin's lymphoma (HL) survivors are known to be at substantially increased risk of solid cancers (SC). However, no investigation has used multivariate modeling to estimate the relative risk (RR), excess absolute risk (EAR), and cumulative incidence for specific attained ages and ages at HL diagnosis. Patients and Methods: We identified 18,862 5-year HL survivors from 13 population-based cancer registries in North America and Europe. Poisson regression was used to evaluate the effects of age at diagnosis, attained age, latency, sex, treatment, and year of diagnosis on the RR and EAR of SC. Results: Among 1,490 identified SC, 850 were estimated to be in excess. For most cancer sites, both RR and EAR decreased with age at HL diagnosis and showed strong dependencies on attained age. For a patient diagnosed at age 30 years and survived to ≥ 40 years, modeled risks were significantly elevated for cancers of the breast (RR = 6.1), other supradiaphragmatic sites (RR = 6.0), and infradiaphragmatic sites (RR = 3.7); the largest RR (20-fold) was observed for malignant mesothelioma. Thirty-year cumulative risks of SC for men and women diagnosed at 30 years were 18% and 26%, respectively, compared with 7% and 9%, respectively, in the general population. For young HL patients, risks of breast and colorectal cancers were elevated 10 to 25 years before the age when routine screening would be recommended in the general population. Conclusion: Multivariable modeling demonstrates for the first time temporal changes in SC risk not evident in unadjusted analyses, and can facilitate the development of individualized risk assessment and the creation of screening strategies for early detection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Tumors of the Brain and Nervous System after Radiotherapy in Childhood
Ron, E., Modan, B., Boice, J. D., Alfandary, E., Stovall, M., Chetrit, A., & Katz, L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191601 · Cited by 934
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
Travis, L. B., Fosså, S. D., Schonfeld, S. J., McMaster, M. L., Lynch, C. F., Storm, H., Hall, P., Holowaty, E., Andersen, A., Pukkala, E., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji278 · Cited by 823
Self-citationPignone, M., Rich, M., Teutsch, S. M., Berg, A. O., & Lohr, K. N. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-2-200207160-00015 · Cited by 741
Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease
Aleman, B. M. P., van den Belt-Dusebout, A. W., Klokman, W. J., van’t Veer, M. B., Bartelink, H., & van Leeuwen, F. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.131 · Cited by 716
Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease
Travis, L. B., Hill, D. A., Dores, G. M., Gospodarowicz, M., van Leeuwen, F. E., Holowaty, E., Glimelius, B., Andersson, M., Wiklund, T., Lynch, C. F., et al. (2003) · JAMA · doi:10.1001/jama.290.4.465 · Cited by 666
Self-citationDores, G. M., Metayer, C., Curtis, R. E., Lynch, C. F., Clarke, E. A., Glimelius, B., Storm, H., Pukkala, E., van Leeuwen, F. E., Holowaty, E. J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.038 · Cited by 565
Self-citationLung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease
Travis, L. B. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.3.182 · Cited by 562
Self-citationCancer Incidence in Five Continents. Comparability and quality of data.
Dm, P., & Cs, M. (1992) · PubMed · Cited by 505
Swerdlow, A. J., Barber, J. A., Hudson, G. V., Cunningham, D., Gupta, R. K., Hancock, B. W., Horwich, A., Lister, T. A., & Linch, D. C. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.498 · Cited by 476
Cited by
Malignant Pleural Mesothelioma
Tsao, A. S., Wistuba, I., Roth, J. A., & Kindler, H. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8523 · Cited by 481
Solid cancers after allogeneic hematopoietic cell transplantation
Rizzo, J. D., Curtis, R. E., Socié, G., Sobocinski, K. A., Gilbert, E., Landgren, O., Travis, L. B., Travis, W. D., Flowers, M. E. D., Friedman, D. L., et al. (2009) · Blood · doi:10.1182/blood-2008-05-158782 · Cited by 439
Self-citationMalignant pleural mesothelioma: history, controversy and future of a manmade epidemic
Røe, O. D., & Stella, G. M. (2015) · European Respiratory Review · doi:10.1183/09059180.00007014 · Cited by 185
Appel, B. E., Chen, L., Buxton, A. B., Hutchison, R. E., Hodgson, D. C., Ehrlich, P. F., Constine, L. S., & Schwartz, C. L. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.3469 · Cited by 77
Self-citationMishra, B., Lawson, G. W., Ripperdan, R., Ortiz, L., & Luderer, U. (2018) · Radiation Research · doi:10.1667/rr15028.1 · Cited by 18
Metadata
- Authors
- Hodgson, D. C., Gilbert, E. S., Dores, G. M., Schonfeld, S. J., Lynch, C. F., Storm, H., Hall, P., Langmark, F., Pukkala, E., Andersson, M., Kaijser, M., Joensuu, H., Fosså, S. D., & Travis, L. B.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-04-20
- Volume
- 25
- Issue
- 12
- Pages
- 1489-1497
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2103004443
- Cited by
- 351
- References
- 22
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma. https://app.cochat.ai/papers/10.1200/jco.2006.09.0936
- The paper
- Hodgson, D. C., Gilbert, E. S., Dores, G. M., Schonfeld, S. J., Lynch, C. F., Storm, H., Hall, P., Langmark, F., Pukkala, E., Andersson, M., Kaijser, M., Joensuu, H., Fosså, S. D., & Travis, L. B. (2007). Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2006.09.0936
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.